Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.34 in the prior trading day, Cardiff Oncology Inc (NASDAQ: CRDF) closed at $2.31, down -1.28%. In other words, the price has decreased by -$1.28 from its previous closing price. On the day, 0.67 million shares were traded. CRDF stock price reached its highest trading level at $2.48 during the session, while it also had its lowest trading level at $2.26.
Ratios:
Our goal is to gain a better understanding of CRDF by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.74 and its Current Ratio is at 4.74. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.Robert W. Baird initiated its Outperform rating on December 08, 2021, with a $19 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 19 ’23 when PACE GARY W bought 30,000 shares for $1.37 per share. The transaction valued at 41,100 led to the insider holds 697,761 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDF now has a Market Capitalization of 118118848 and an Enterprise Value of 62137956. For the stock, the TTM Price-to-Sale (P/S) ratio is 168.99 while its Price-to-Book (P/B) ratio in mrq is 2.28. Its current Enterprise Value per Revenue stands at 90.317 whereas that against EBITDA is -1.351.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $6.42, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is -17.78%, while the 200-Day Moving Average is calculated to be -26.28%.
Shares Statistics:
The stock has traded on average 737.64K shares per day over the past 3-months and 559530 shares per day over the last 10 days, according to various share statistics. A total of 48.73M shares are outstanding, with a floating share count of 47.17M. Insiders hold about 7.76% of the company’s shares, while institutions hold 24.93% stake in the company. Shares short for CRDF as of 1731628800 were 7715250 with a Short Ratio of 10.46, compared to 1728950400 on 7315126. Therefore, it implies a Short% of Shares Outstanding of 7715250 and a Short% of Float of 15.47.
